Home › Funds › Propel Bio Management, LLC › PROK
Propel Bio Management, LLC position in PROK
PROKIDNEY CORP · Health Care
Propel Bio Management, LLC reported holding 2,009,733 shares of PROK (PROKIDNEY CORP) in its Q3 2026 13F filing — a position valued at US$3.3M, representing 1.77% of its reported portfolio and ranking #18 among its reported holdings. Propel Bio Management, LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Propel Bio Management, LLC's PROK position evolved
Propel Bio Management, LLC first disclosed a stake in PROK in Q3 2026 at 2,009,733 shares (US$3.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 2.01M | $3.34M | New |
About PROK and 13F data
PROK (PROKIDNEY CORP) is a Health Care company. 32 other funds we track also report a position in PROK — the largest reported positions include MONTANOVA CAPITAL, LLC (US$25.2M), Artia Global Partners LP (US$3.7M), Brown University (US$1.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PROK
- MONTANOVA CAPITAL, LLC 12.34M sh · $25.18M · Q2 2026
- Artia Global Partners LP 1.81M sh · $3.69M · Q2 2026
- Brown University 1.00M sh · $1.66M · Q3 2026
More on Propel Bio Management, LLC
FAQ
How long has Propel Bio Management, LLC held PROK?
Propel Bio Management, LLC has disclosed PROK holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Propel Bio Management, LLC's current position in PROK?
As of Q3 2026, Propel Bio Management, LLC holds 2.01M shares of PROK (PROKIDNEY CORP), valued at $3.34M, representing 1.77% of its reported portfolio and ranking #18.
Has Propel Bio Management, LLC been buying or selling PROK?
In the latest 13F filing (Q3 2026), Propel Bio Management, LLC newly opened its position in PROK.
Which other funds hold PROK?
Other major institutional holders of PROK include MONTANOVA CAPITAL, LLC, Artia Global Partners LP, Brown University, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.